Loading viewer...
investor_presentation
Format: PDF investor_presentation
FEBRUARY 3, 2021 First Quarter of Fiscal 2021 EarningsSLIDES & REMARKS
Fiscal 2021 EarningsSLIDES & REMARKSSAFE HARBOR STATEMENT
The information contained in and discussed in these slides and prepared
remarks may include “forward-looking statements” within the meaning
of federal securities regulations. These forward-looking statements
include a number of risks, uncertainties, and other factors, including those
described in CMC Materials’ filings with the Securities and Exchange
Commission (SEC), that could cause actual results to differ materially from
those described by these forward-looking statements. CMC Materials
assumes no obligation to update this forward-looking information.
2 © Copyright 2021 CMC Materials, Inc.These prepared remarks should be read in conjunction with CMC’s earnings
release that was posted on CMC’s website on February 3, 2021. In addition,
these detailed remarks supplement the commentary that the company will
make on its earnings conference call on February 4, 2021.PRESIDENT & CEO REMARKS
To date, we have not seen a meaningful impact from
the COVID-19 pandemic (“Pandemic”) on our supply
chain, and I would like to take this opportunity to
again express my gratitude and appreciation to our
teams globally for their efforts to keep our employees
safe, and to manufacture and deliver solutions to our
customers without interruption.
I am also pleased to announce that we have recently
released our inaugural Corporate Sustainability
Report, which is available on our website . Our
report is aligned with the SASB and TCFD reporting
frameworks, which provide a consistent and objective
way for us to report our performance in this important
At CMC Materials, we have a great tradition of
employee-driven projects and achievements in the
area of conservation and sustainability, and we
believe those results show that our actions align with
Preview truncated — download the full document for the complete content.
presentation
Regeneron Pharmaceuticals, Inc.
investor_presentation
Etrion